Category: Mergers and Acquisitions

March 23, 2021

Anixa Biosciences, Inc. (NASDAQ: ANIX) (“Anixa” or the “Company”), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that, due to demand, the underwriter has agreed to increase the size of the previously […]

February 9, 2021

Tmunity Therapeutics, Inc., a clinical-stage biotherapeutics company specifically designed to deliver on the bold promise to ‘uncancer the world’ by creating the best T cell medicines for solid tumor patients, today announced the expansion of its T cell engineered therapy […]

February 8, 2021

Jazz Pharmaceuticals has announced that it will acquire London-headquartered biopharma company GW Pharma for a total consideration of $7.2bn. GW is focused on the discovery and development of therapeutics from its proprietary cannabinoid product platform. The company’s lead product is […]

February 5, 2021

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced the pricing of its public offering of 5,000,000 shares of its common stock at a […]

February 4, 2021

Stella Diagnostics, Inc. (OTC PINK:JMDP) (“Stella” or “The Company”) announced today that they have entered into a partnership with mProbe, Inc., a leading biotechnology company based in California. The aims of the partnership were to build, optimize and further validate […]

December 31, 2020

Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and […]

November 13, 2020

Urovant began life as an offshoot of Vivek Ramaswamy’s Roivant goliath, but is now firmly a part of the Sumitovant Biopharma family after the life science company bought up the rest of its shares in the biotech. This comes around […]

October 28, 2020

Bayer AG has acquired Asklepios BioPharmaceutical, Inc. (AskBio) for $2 billion upfront and potential success-based milestone payments of up to $2 billion. The U.S.-headquartered biopharma specializes in the research, development and manufacturing of gene therapies across different therapeutic areas. AskBio’s […]

August 19, 2020

Johnson & Johnson has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. for approximately $6.5 billion in cash. This acquisition expands Janssen Pharmaceutical’s portfolio in immune-mediated diseases into autoantibody-driven disease. J&J gains global rights to nipocalimab (M281), a […]

June 23, 2020

Members of the European Commission, the European Medicines Agency, and the US FDA held their 2020 bilateral regulatory meeting virtually from June 18–19, 2020. The agencies discussed ongoing joint initiatives and strategies for collaborating in the future. The agencies, which […]

June 19, 2020

PDS Biotechnology said June 17 that it signed an agreement with Farmacore Biotechnology to co-develop Versamune®-CoV-2FC. PDS and Farmacore agreed to accelerate development of the vaccine candidate into Phase 1 clinical testing in Brazil, with initial financial support to be […]

June 4, 2020

Novavax, a late-stage biotechnology company developing the NVX-CoV2373 coronavirus vaccine candidate against SARS-CoV-2 has secured two manufacturing agreements for large-scale GMP (good manufacturing practice) manufacture of components of the vaccine candidate. NVX CoV2373 is engineered from the genetic sequence of […]